US EditionBrazil Legalizes Medical Cannabis Cultivation, Widens Patient Access
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.6 Articles
6 Articles
The Brazilian National Health Surveillance Agency (Anvisa) approved, last Wednesday (28), a new regulatory framework that authorizes the cultivation of cannabis for exclusively medicinal purposes and expands the use of plant-based therapies in Brazil. The decision fulfills a 2024 ruling by the Superior Court of Justice (STJ). The regulation does not allow the recreational use of cannabis nor does it authorize cultivation by individuals. Planting…
It has been almost twenty years since the Brazilian Drug Law stipulated that it is permitted to cultivate marijuana for medicinal and scientific purposes—provided that the Federal Government authorizes it. The problem is that, for “political” reasons, this authorization never came. This week, the National Health Surveillance Agency (Anvisa) finally opened this closet, approving the first rules for the legal cultivation of cannabis in Brazil and,…
The Brazilian Health Authority (Anvisa) has adopted a decision authorising the cultivation of cannabis for medical purposes in the country and allowing the sale of cannabidiol in pharmacies, as well as the national production of medicines from this plant. The measure corresponds to an order of the Supreme Court, which had requested the regulatory authority in 2024 to establish a legal framework for the cultivation of [...] The post Brazil approv…
Brazil Approves Licensed Medical Marijuana Cultivation for First Time, Expands Patient Access to Cannabis Treatments
The Marijuana Herald - Marijuana news and information (Photo credit: Shutterstock). Brazil’s national health agency Anvisa has given approval to sweeping new rules that, for the first time in the nation’s history, allow the cultivation of marijuana within the country for pharmaceutical and scientific purposes, while also expanding access to cannabis-based treatments for patients. The decision by Anvisa follows a ruling by the Superior Court of J…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
